Table 4. – Outcomes according to the IL-1β in females.
Female - Total | < 60 years | > 60 years | |||||||
---|---|---|---|---|---|---|---|---|---|
2 years follow-up | Low IL-1β | High IL-1β | p | Low IL-1β | High IL-1β | p | Low IL-1β | High IL-1β | p |
All-cause mortality | 21 (42.0) | 29 (58.0) | 0.221 | 0 (0.0) | 3 (100.0) | 0.118 | 19 (40.4) | 28 (59.6) | 0.140 |
Cardiovascular mortality | 12 (35.3) | 22 (64.7) | 0.071 | 0 (0.0) | 3 (100.0) | 0.118 | 10 (32.3) | 21 (67.7) | 0.034 |
Fatal or new non-fatal MI | 10 (35.7) | 18 (64.3) | 0.117 | 2 (33.3) | 4 (66.7) | 0.438 | 7 (31.8) | 15 (68.2) | 0.075 |
Values are n (%). IL-1β: Interleukin - 1beta. MI: myocardial infarction. Chi-square test.